The CRISPR-genomic cure market involves the development of therapies and drugs that use CRISPR-Cas genome editing technology to cure complex diseases by modifying the human genome. CRISPR-based therapies hold promise for treating various genetic disorders by precisely editing DNA at the sites of defective genes. The technology allows corrections to be made directly in a patient's cells and tissue, offering potential cures.

The global Crispr Genomic Cure Market is estimated to be ... Read more